1 – 4 of 4
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
2017 ESC/EACTS Guidelines for the management of valvular heart disease
(
- Contribution to journal › Article
- 2011
-
Mark
Use of Cardiac Computed Tomography Prior to Percutaneous Coronary Sinus Device Placement for the Treatment of Mitral Regurgitation Reply
(
- Contribution to journal › Letter
-
Mark
Transcatheter Implantation of the MONARC Coronary Sinus Device for Mitral Regurgitation 1-Year Results From the EVOLUTION Phase I Study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for The Treatment of Mitral Regurgitation).
(
- Contribution to journal › Article
- 2003
-
Mark
Ximelagatran Compared with Warfarain for prevention of thromboembolism in patients with nonvalvular atiral fibrillaton: Rationale. Objectives and design of a pair of clinical trials and baseline patient characteristics (SPORTIF III and V).
(
- Contribution to journal › Article